Smart People: Jeff Elton
Jeff Elton, chief executive of ConcertAI, talks to PharmaTimes about the pandemic's impact on oncology trials in the US
11th May 2021
Web Exclusives
Predicting risk
How pharma can use natural language processing for drug safety predictions
11th May 2021
Getting the brand story right
Optimising value propositions for payers – some simple rules
10th May 2021
Consumer vision: the decade ahead
A theme of the decade that health chief marketing officer's can’t afford to ignore
7th May 2021
Flu is ever evolving and so are we
There is no doubt that flu will return, but we are prepared for it, says Beverly Taylor
6th May 2021
Optimising regulatory information management
Extracting the value from data integration
30th April 2021
COVID and the growing threat of counterfeit medicines
Has the pandemic created a perfect storm for counterfeit pharmaceuticals?
29th April 2021
Raising the bar
Enter the Patient Partnership Index 2021 to define the future of patient partnerships
29th April 2021
Has pharma missed the boat?
Analysis of how the pharmaceutical sector is viewed through its Environmental, Social and Corporate Governance (ESG) actions indicates that the moment for reputational enhancement might be passing
28th April 2021
NICE steps into the future
Sharmila Nebhrajani on the Institute's new five-year strategy to help bring the benefits of innovations to patients more quickly
20th April 2021
Humanising pharma for a new world through design
Through strong brand communication and design, we are starting to see a new side to pharma and life science and healthcare sectors
19th April 2021
Opportunities for innovation
Why innovation and continued virtual engagement is key to the future success of the med tech industry
8th April 2021
Lock and key
The key three cybersecurity concerns for the pharmaceutical industry in 2021
1st April 2021
Digital healthcare in primary care
The next generation of digitised collaborative and shared primary care services
24th March 2021
A new normal
Cost, participation, and virtual trials – the three challenges facing clinical organisations
22nd March 2021
